Orchestra BioMed Holdings (OBIO) Change in Receivables (2022 - 2025)
Historic Change in Receivables for Orchestra BioMed Holdings (OBIO) over the last 4 years, with Q3 2025 value amounting to -$31000.0.
- Orchestra BioMed Holdings' Change in Receivables fell 18857.14% to -$31000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$78000.0, marking a year-over-year decrease of 36896.55%. This contributed to the annual value of -$22000.0 for FY2024, which is 83333.33% down from last year.
- Latest data reveals that Orchestra BioMed Holdings reported Change in Receivables of -$31000.0 as of Q3 2025, which was down 18857.14% from -$6000.0 recorded in Q2 2025.
- Over the past 5 years, Orchestra BioMed Holdings' Change in Receivables peaked at $95000.0 during Q2 2023, and registered a low of -$85000.0 during Q3 2023.
- In the last 4 years, Orchestra BioMed Holdings' Change in Receivables had a median value of -$4500.0 in 2025 and averaged -$6000.0.
- Examining YoY changes over the last 5 years, Orchestra BioMed Holdings' Change in Receivables showed a top increase of 940000.0% in 2023 and a maximum decrease of 63125.0% in 2023.
- Orchestra BioMed Holdings' Change in Receivables (Quarter) stood at $16000.0 in 2022, then decreased by 18.75% to $13000.0 in 2023, then crashed by 392.31% to -$38000.0 in 2024, then increased by 18.42% to -$31000.0 in 2025.
- Its last three reported values are -$31000.0 in Q3 2025, -$6000.0 for Q2 2025, and -$3000.0 during Q1 2025.